Home
About Us
Our Science
Pipeline
Careers
Media
Contact

Select Page

Panelist at Finance and Accounting for Bioscience Companies (CFO Leslie Shulze)

Sep 30, 2021

Click to learn more

Search

Recent Posts

Attacking Neurodegenerative Diseases with Protein Degraders
Origami Brings Protein Degradation to Neurodegenerative Disorders
Founder Spotlight #36: Beth Hoffman @ Origami Therapeutics
CEO Beth Hoffman guest on the Personalized Medicine Podcast
Origami named part of the W22 Batch at Y Combinator

Recent Comments

No comments to show.

origami_therapeutics_logo_white-01

Origami Therapeutics, Inc.
10210 Campus Point Road, Suite 150
San Diego, CA 92121

info@origamitherapeutics.com